Please assess the completion status of the following clinical trial:

Trial Title: Study of Treatment of Lisfranc Injuries

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~Stratum 1:~* Nondislocated fractures affecting tarsometatarsal (TMT) joints II and III~* Dislocation \<5mm between medial cuneiforme and base of II metatarsal (MT)~* No fractures affecting TMT joints IV and V~Stratum 2:~* Affected joints TMT II- III + any other TMT~* Any dislocation \>2mm (fracture or TMT joint)~* Dislocation \>5mm between medial cuneiforme and base of II MT~Exclusion Criteria:~* Open fractures~* Extra-articular metatarsal (MT) fractures~* Extremely comminuted fractures with bone loss, and slight chance of gaining proper reduction with screws~* Patients with multiple fractures~* Patients with weak co-operation (dementia, alcohol use, etc.)~* Patients with significant neuropathy or some other neurological condition, diabetes and rheumatoid arthritis~* Patients with severe circulatory disorder of the lower limb~* Injuries over 14 days~* Patients with previous foot injury or surgery~* Pregnancy~* Patients who refuse to participate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Open reduction and internal fixation (Type: ACTIVE_COMPARATOR): After operative treatment non-weightbearing cast immobilisation for 6 weeks. Cast will be changed after 2 weeks. After the 6 weeks cast will be replaced with orthotics. Orthotics will remain for 4 weeks.
- Primary Arthrodesis (Type: ACTIVE_COMPARATOR): After operative treatment non-weightbearing cast immobilisation for 6 weeks. Cast will be changed after 2 weeks. After the 6 weeks cast will be replaced with orthotics. Orthotics will remain for 4 weeks.
- Conservative treatment (Type: ACTIVE_COMPARATOR): Non-weightbearing cast immobilisation for 6 weeks. Cast will be changed after 2 weeks. After the 6 weeks cast will be replaced with orthotics. Orthotics will remain for 4 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).